Inhibrx Biosciences, Inc. (INBX)

Inhibrx Biosciences, Inc. (INBX) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $1.4B; returns 1 day -3.8%, 1 week +4.0%, 1 year +229.3%.

Inhibrx Biosciences, Inc. (INBX) is a clinical-stage biopharmaceutical company headquartered in La Jolla, California, primarily focused on the discovery and development of novel biologic therapeutic candidates for the treatment of various cancers and rare diseases.

Groups INBX belongs to

• Biotechnology
• Biopharmaceutical
• Clinical Stage Biotech
• Clinical Stage Biopharma
• Clinical Stage
• Life Sciences
• Healthcare
• Rare Diseases
• Oncology
• Biologics
• Cancer Therapeutics

INBX financial model: income statement, cash flow and balance sheet